FIELD: medicine, pharmacy, pharmaceutical technology. SUBSTANCE: pharmaceutical composition has an effective amount of haloperidol as an active component and the following special additions, mas. pts. /1 mas. pts. of haloperidol: lactose, 41.1-57.0; starch, 8.2-12.5; aerosil, 1.0-2.0; talc, 0.2-2.0; stearate, 0.2-0.9. To prepare the composition haloperidol taken in effective amount in mixture with lactose, starch and aerosil is wetted with 3% starch glue paste. Mixture is passed through granulator, wetted granulate is dried, dried granules are passed through granulator, powdered with a mixture of starch with talc and stearate and tabletted. Invention can be used for treatment of patients with psychotic diseases and vomiting of different genesis. Development of new tabletted form of haloperidol corresponds to all requirements of State Pharmacopoeia of XI Edition. EFFECT: higher efficiency. 8 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL ANTIULCEROUS COMPOSITION AND METHOD OF ITS PREPARING | 2001 |
|
RU2179022C1 |
PHARMACEUTICAL COMPOSITION WITH ANTIDIABETIC EFFECT AND METHOD OF ITS PREPARING | 2000 |
|
RU2177318C1 |
METHOD FOR PRODUCING COMPOSITION AND COMPOSITION SHOWING ANTIBACTERIAL ACTIVITY | 2001 |
|
RU2182825C1 |
ANTI-ARRHYTHMIC, ANTI-ANGINAL PHARMACEUTICAL COMPOSITION | 2002 |
|
RU2212236C1 |
PHARMACEUTICAL COMPOSITION OF ANTIHYPERTENSIVE AND DIURETIC ACTION, AND METHOD FOR ITS OBTAINING | 2002 |
|
RU2201751C1 |
PHARMACEUTICAL COMPOSITION ELICITING ANTIBACTERIAL EFFECT | 2001 |
|
RU2181290C1 |
PHARMACEUTICAL COMPOSITION SHOWING ANTITUBERCULOSIS ACTIVITY | 1999 |
|
RU2146130C1 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DIABETES MELLITUS (VARIANTS) | 2003 |
|
RU2241449C1 |
PHARMACEUTICAL COMPOSITION WITH CARDIOSELECTIVE BETA-ADRENERGIC ANTAGONIST (VARIANTS) | 2004 |
|
RU2256447C1 |
PHARMACEUTICAL COMPOSITION SHOWING ANTIULCER AND ANTIACID EFFECT | 2001 |
|
RU2195292C1 |
Authors
Dates
2002-01-20—Published
2001-02-02—Filed